Operation Broadsword was conducted from January 28 to 30, 2020. In just two days, investigators from both governments examined more than 800 shipments, identifying approximately 500 different FDA-regulated products. These included drugs to treat and/or alleviate serious diseases such as various forms of cancer and HIV. Many of the shipments, which included opioid products, had been re-routed through third countries to conceal their point of origin and avoid detection.

Similar to the European operation PANGEA, a longer-term cooperation is planned between the USA and India. An exchange of "best practices" should help to better target criminal actors at both ends.

Source:

FDA: News Release